Publications by authors named "Stephen Keefe"

Claim this Profile
P
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Stephen M Keefe

Lancet· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to P.-H. Luo et al.
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, Cumhur Tekin, Stephen M Keefe

J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Stephen M Keefe

Lancet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
Krishnansu S Tewari, Nicoletta Colombo, Bradley J Monk, Coraline Dubot, M Valeria Cáceres, Stephen M Keefe

JAMA Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, Coraline Dubot, M Valeria Caceres, Stephen M Keefe

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.
Jonathan A Ledermann, Ronnie Shapira-Frommer, Alessandro D Santin, Alla S Lisyanskaya, Sandro Pignata, Stephen M Keefe

Gynecol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, Alessandro D Santin, Emeline Colomba, Stephen Keefe

N Engl J Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Nicoletta Colombo, Coraline Dubot, Domenica Lorusso, M Valeria Caceres, Kosei Hasegawa, Stephen M Keefe

N Engl J Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer.
Estrid Høgdall, Claus Høgdall, Thao Vo, Wei Zhou, Lingkang Huang, Stephen M Keefe

Int J Gynecol Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE-100.
Shin Nishio, Koji Matsumoto, Kazuhiro Takehara, Naoki Kawamura, Kosei Hasegawa, Stephen Keefe

Cancer Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible.
Tomoko Freshwater, Haojie Li, Chandni Valiathan, Mengyao Li, Rodolfo Perini, Stephen Keefe

Am J Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy.
Karl Patterson, Vimalanand Prabhu, Ruifeng Xu, Haojie Li, Yang Meng, Stephen Keefe

Eur Urol Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
Anna B Catino, Rebecca A Hubbard, Julio A Chirinos, Ray Townsend, Stephen Keefe

Circ Heart Fail· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.
Arjun V Balar, Daniel Castellano, Peter H O'Donnell, Petros Grivas, Jacqueline Vuky, Stephen M Keefe

Lancet Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma.
Vivek Narayan, Stephen Keefe, Naomi Haas, Le Wang, Igor Puzanov

Clin Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.
Jeffrey S Weber, Laura A Levit, Peter C Adamson, Suanna S Bruinooge, Howard A Burris, Stephen M Keefe

J Clin Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovation in Bladder Cancer Immunotherapy.
H Barton Grossman, Donald L Lamm, Ashish M Kamat, Stephen Keefe, John A Taylor

J Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer.
Vivek Narayan, Ronac Mamtani, Stephen Keefe, Thomas Guzzo, S Bruce Malkowicz

Cancer Res Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma.
Orvar Gunnarsson, Nicklas R Pfanzelter, Roger B Cohen, Stephen M Keefe

Cancer Manag Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database.
Ronac Mamtani, Kevin Haynes, Ben Boursi, Frank I Scott, David S Goldberg, Stephen M Keefe

Cancer Epidemiol Biomarkers Prev· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.
Jeffrey S Weber, Laura A Levit, Peter C Adamson, Suanna Bruinooge, Howard A Burris, Stephen M Keefe

J Clin Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.
Ronac Mamtani, Nick Pfanzelter, Kevin Haynes, Brian S Finkelman, Xingmei Wang, Stephen M Keefe

Diabetes Care· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.
Melody Ju, Gary D Kao, David Steinmetz, Sanjay Chandrasekaran, Stephen M Keefe

Cancer Biol Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
Benjamin Goldsmith, Brian C Baumann, Jiwei He, Kai Tucker, Justin Bekelman, Stephen M Keefe

Int J Radiat Oncol Biol Phys· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of sorafenib-related adverse events: a clinician's perspective.
Marcia S Brose, Catherine T Frenette, Stephen M Keefe, Stacey M Stein

Semin Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis